====== Oak Valley Health ======

{{ ::ovhlogo.jpeg?200|}}

===== COVID-19 =====

Oak Valley Health released a staggering joint statement with the [[Regional Municipality of York]], [[MacKenzie Health]], and [[Southlake Regional Health Centre]] on October 1, 2021 stating, “​​unvaccinated individuals are prolonging the pandemic and are the driving force behind the increase in cases and hospitalizations across all four York Region hospitals.”((Stationwala, A., Marr, J., Krystal, A., Emmerson, W., & Gould, R. (2021, October 1). //Joint statement from The Regional Municipality of York, Mackenzie Health, Oak Valley Health and Southlake Regional Health Centre on COVID-19.// Oak Valley Health. Retrieved December 1, 2021, from https://www.oakvalleyhealth.ca/sites/default/files/Joint_Statement%20_Vaccinations.pdf))

Oak Valley is part of the ”COVID-19 Cohort Study (CCS): Study of the epidemiology of COVID-19 in healthcare workers and their households” run by the [[Toronto Invasive Bacterial Diseases Network]] (TIBN) at [[Mount Sinai Hospital]]. The webpage of the study is sponsored by [[:pharmaceutical_companies:Pfizer]].((Nadarajah, J. //Markham Stouffville Hospital — TIBDN.// Toronto Invasive Bacterial Diseases Network. Retrieved December 1, 2021, from https://archive.ph/7JcDT)) The investigators of this study are former [[National Advisory Committee on Immunization]] (NACI) member and current [[Ontario COVID-19 Science Advisory Table]] member [[Allison McGeer]]((Semeniuk, I. (2021, May 11). //Once a little-known health body, NACI finds itself in the pandemic spotlight over COVID-19 vaccine debate.// The Globe and Mail. Retrieved November 9, 2021, from https://archive.ph/OZ89j)) ((Ontario COVID-19 Science Advisory Table. (2021, April 13). About Us. Retrieved November 3, 2021, from https://archive.ph/b7aFB)) (who has received funding from [[:pharmaceutical_companies:Pfizer]], [[:pharmaceutical_companies:Moderna]], [[:pharmaceutical_companies:Merck]], [[:pharmaceutical_companies:Medicago]], [[:pharmaceutical_companies:Janssen]], [[:pharmaceutical_companies:GlaxoSmithKline]] and [[:pharmaceutical_companies:AstraZeneca)]],((Yau, K., Abe, K. T., Naimark, D., Oliver, M. J., Perl, J., Leis, J. A., Bolotin, S., Tran, V., Mullin, S. I., Shadowitz, E., Gonzalez, A., Sukovic, T., Garnham-Takaoka, J., de Launay, K. Q., Takaoka, A., Straus, S. E., McGeer, A. J., Chan, C. T., Colwill, K., . . . Hladunewich, M. A. (2021). //Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing Hemodialysis.// JAMA Network Open, 4(9), e2123622. https://doi.org/10.1001/jamanetworkopen.2021.23622)) ((Abe, K. T., Hu, Q., Mozafarihashjin, M., Samson, R., Manguiat, K., Robinson, A., Rathod, B., Hardy, W. R., Wang, J. H., Iskilova, M., Pasculescu, A., Fazel-Zarandi, M., Li, A., Paterson, A., Chao, G., Green, K., Gilbert, L., Barati, S., Haq, N., . . . Gingras, A. C. (2021). //Neutralizing antibody responses to SARS-CoV-2 variants in vaccinated Ontario long-term care home residents and workers.// medRxiv. Preprint. https://doi.org/10.1101/2021.08.06.21261721)) ((Ireland, N. (2021, September 28). //COVID-19 vaccine boosters recommended for long-term care residents, national advisory committee says.// CBC News. Retrieved November 20, 2021, from https://archive.ph/NXtRs)) [[Brenda Coleman]] (who has received funding from [[:pharmaceutical_companies:Seqirus]])((Coleman, B. L., Sanderson, R., Haag, M. D. M., & McGovern, I. (2021). //Reply to Letter to the Editor by Yin et al.// Influenza and Other Respiratory Viruses, 15(6), 828–829. https://doi.org/10.1111/irv.12895)) and [[Dawn Bowdish]] (who has received funding from [[:pharmaceutical_companies:Pfizer]]).((Bowdish, D. M. E. (2013, February 11). //Dr. Dawn Bowdish receives a research award from the Ontario Lung Association and Pfizer Canada (and gets to attend a swanky event to receive it!).// Bowdish Lab. Retrieved December 1, 2021, from https://archive.ph/AQqx1)) ((Bowdish, D. M. E. (2011, July 3). //Dawn wins ASPIRE-Pfizer New Investigator Award.// Bowdish Lab. Retrieved December 1, 2021, from https://archive.ph/Dvre1))